If future research continues to support the heart and kidney benefits seen in current trials, GLP-1 medicines could become part of a broader strategy aimed not only at managing disease but potentially delaying some of its most serious consequences
Many of these emerging players are based in China, indicating a potential shift in market dynamics unless major licensing or acquisition deals occur
Antidepressants may affect the weight loss potential of GLP-1 drugs, but it may depend on your dosage
Before enrolling, verify the clinician, medication and form, dose-price schedule, pharmacy or manufacturer channel, cash due today, renewal amount, annual commitment, and cancellation rules
Each receptor plays a different role in managing your weight and metabolism
The Efficacy Ladder: How Every GLP-1 Compares Cross-trial comparisons are imperfect because patient populations, durations, and baseline weights differ